Dr. Chassidy Johnson

Chassidy Johnson PhD, joined BioView in 2022 as Chief Scientific Officer. Dr. Johnson has more than 10 years industry experience with a passion for single cell technologies that can enable liquid biopsies.  Prior to joining BioView she held roles in Scientific and Clinical Affairs leading teams in global collaborations, clinical studies, assay development, validation, regulatory submissions and BioPharma Services at Epic Sciences, Biolidics Ltd, Deepcell Inc., and IsoPlexis.

Dr. Johnson received her PhD from Tulane University in Microbiology and Immunology and was a Post-doctoral fellow at University of California, Irvine.